The price of the insulin has skyrocketed in recent years. But a Utah company is ready to manufacture and distribute much cheaper versions. Dan Liljenquist of CivicaRx talks about their long journey to this point, how difficult it can be to get lower cost alternatives on the market, and why is getting cheaper insulin on the market good for consumers and for business.

See omnystudio.com/listener for privacy information.